Meetings, Events and Conference Coordinators, Inc.P.O. Box 430376Miami, FL 33243-0376

_____________PRST STDUS Postage

PAIDMiami, FL

Permit No. 1429

12th Annual New Orleans Summer Cancer Meeting“Oncogenic Targets and Immune Modulation: Ways to Fight Against Cancer”

July 21-23, 2017 The Roosevelt Hotel New OrleansNew Orleans, LA

July 21-23, 2017

ROOSEVELT HOTEL New Orleans

Program Chair and Conference DirectorEdgardo S. Santos, M.D., FACP

Educational CommitteePasquale W. Benedetto, M.D. • Chancellor Donald, M.D.

Dorothy Green • Mark Pegram, M.D.Daniel Petrylak, M.D. • Luis E. Raez, M.D., FACP, FCCP

Christian Rolfo, M.D. • Hope Rugo, M.D.Eduardo Sotomayor, M.D.

Adrienne M. Vazquez, MSN, ACNP-BC, AOCN

Jointly Sponsored by:

FLORIDA SOCIETY OF CLINICAL ONCOLOGY LOUISIANA STATE ONCOLOGY SOCIETY

Sponsored by:THE MEDICAL EDUCATOR CONSORTIUM

12 th AnnuAl new OrleAns summer CAnCer meeting“Oncogenic Targets and Immune Modulation: Ways to Fight Against Cancer”

PROGRAM CHAIREdgardo S. Santos, M.D., FACPMedical Director of Cancer Research Thoracic and Head and Neck Cancer Programs, Lynn Cancer Institute/Boca Raton Regional HospitalAssociate Professor of Clinical Biomedical ScienceCharles E. Schmidt College of Medicine Florida Atlantic University

DISTINGUISHED GUEST FACULTYPasquale W. Benedetto, M.D.Professor of MedicineDirector, Hematology/Oncology Fellowship Program University of Miami/Sylvester Comprehensive Cancer CenterMiami, FL

Mitesh J. Borad, M.D.Director, Phase I Drug DevelopmentMayo ClinicPhoenix, AZ

Ana Botero, M.D.Department of Radiation OncologyMemorial Cancer InstituteMemorial Health Care SystemHollywood, FL

Aurelio Castrellon, M.D.Breast Cancer ProgramMemorial Cancer InstituteMemorial Health Cancer SystemHollywood, FL

Sajeel Chowdary, M.D. Director, Medical Neuro-OncologyMarcus Neuroscience InstituteDirector, Neuro-Oncology Program / NeurologyLynn Cancer InstituteBoca Raton Regional HospitalBoca Raton, FL

Gerardo Colon-Otero, M.D.Associate Professor of MedicineMayo Clinic School of Medicine - Mayo ClinicJacksonville, FL

Lorinda A. Coombs, MSN, FNP-BC, AOCNPAssistant Clinical Professor School of Nursing/Community Health SystemsUniversity of California San FranciscoSan Francisco, CA

Michael Diaz, M.D.Florida Society of Clinical Oncology PresidentCommunity Oncology Alliance Vice-President/SecretaryFCS Director of Patient AdvocacyFlorida Cancer Specialists and Research InstituteSt. Petersburg, FL

Chancellor Donald, M.D.President - Louisiana Oncology Society; Medical Director - Our Lady of Lourdes Oncology Service Line; Clinical Assistant Professor - Tulane University Department of Hematology/Oncology; Standing Member of Committee on Practice - American Society of Hematology; CAC (Carrier Advisory Committee) Representative for the State of Louisiana; Board of Directors - Community Oncology AllianceNew Orleans, LA

Hugo F. Fernandez, M.D.Senior Member, Associate Chief and Clinical DirectorDepartment of Blood and Marrow TransplantationMoffitt Cancer CenterTampa, FL

Sergio A. Giralt, M.D.Chief, Adult Bone Marrow Transplant ServiceMelvin Berlin Family Chair in Multiple MyelomaMemorial Sloan Kettering Cancer CenterNew York, NY

Barbara J. Gitlitz, M.D.Associate Professor of Medicine, USC Keck School of MedicineLos Angeles, CA

Sybil Green JD, MHA, RPhDirector of Coverage and ReimbursementAmerican Society of Clinical Oncology

Dorothy Green PhillipsExecutive DirectorFlorida Society of Clinical OncologyRiverview, FL

Omid Hamid, M.D.Chief of Research/ Immuno-Oncology, The Angeles Clinic Co-Director, Cutaneous Malignancy Program – Cedars SinaiThe Angeles Clinic & Research InstituteLos Angeles, CA

Thomas Herzog, M.D.Clinical Director of the UC Cancer InstituteProfessor, Division of Gynecologic OncologyCincinnati, OH

Steven M. Horwitz, M.D.Associate AttendingLymphoma ServiceMemorial Sloan-Kettering Cancer CenterNew York, NY

Brian Hunis, M.D.Director of Head & Neck Cancer and Quality Clinical Associate Professor of MedicineHerbert Wertheim College of MedicineFlorida International UniversityHollywood, FL

Jennifer R. Klemp, Ph.D., MPHFounder/CEO, Cancer Survivorship TrainingAssociate Professor of Medicine, Division of Clinical OncologyDirector, Cancer SurvivorshipUniversity of Kansas Medical CenterCancer Center and Medical PavillonWestwood, KS

Rami Komrokji, M.D.Clinical Director, Associate Member, Department of Malignant HematologyH. Lee Moffitt Cancer Center & Research Institute Tampa, Florida

Alan Koletsky, M.D.Affiliate Assistant Professor of Clinical Biomedical ScienceCharles E. Schmidt College of MedicineFlorida Atlantic UniversityGenitourinary Cancer Research ProgramLynn Cancer InstituteBoca Raton, FL

Distinguished Faculty

Distinguished FacultyJessica MacIntyre, ARNP, NP-CSylvester Comprehensive Cancer CenterUniversity of Miami Miller School of MedicineMiami, FL

John Marshall, M.D.Director, The Ruesch Center for the Cure of GI CancersChief, Hematology and OncologyLombardi Comprehensive Cancer CenterGeorgetown University Medical CenterWashington, DC

Eriberto Marques, M.D.Medical Director of Santa Agueda HospitalDepartment of Medical OncologyMember of SBOC/SLACOMRecife-PE, Brazil

Robert E. Marx, D.D.S.Professor of Surgery; Director of Research; Chief, Division of Oral and Maxillofacial Surgery, Department of Surgery, University of Miami Miller School of Medicine; Diplomate, American Board of Oral and Maxillofacial SurgeryMiami, FL

Tarek M. Mekhail, MD, MSc, FRCSI, FRCSEdAssociate Director, Florida Hospital Cancer InstitutePresident, Cancer Institute of FloridaMedical Director, Thoracic Cancer ProgramAssociate Professor – University of Central FloridaOrlando, FL

Taofeek K. Owonikoko, M.D., Ph.D.Director, Thoracic Oncology ProgramAssistant Professor, Emory School of MedicineAtlanta, GA

Mark Pegram, M.D.Professor of MedicineDirector of the Breast Cancer ProgramCo-Director of Molecular Therapeutic ProgramStanford UniversityPalo Alto, CA

Daniel Petrylak, M.D.Director, Genitourinary Oncology Research ProgramCo Director, Signal Transduction ProgramYale Comprehensive Cancer CenterYale School of MedicineNew Haven, CT

Javier Pinilla Ibarz, M.D.Associate Member and Director of Immunotherapy Malignant Hematology Department, H. Lee Moffitt Cancer Center & Research InstituteTampa, FL

Luis E. Raez, M.D.Director, Memorial Cancer InstituteDirector, Clinical Oncology ResearchMemorial Health Care SystemClinical Associate Professor of MedicineHerbert Wertheim College of MedicineFlorida International UniversityBroward, FL

Thomas M. Reske, M.D., PhDAssistant Professor of Clinical MedicineSection of Hematology and OncologySection of Geriatric MedicineLSU Healthcare Network Clinic Geriatrics New Orleans, LA

Christian Rolfo, M.D.Head of Unit Phase I - Early Clinical Trials Director of Clinical Trial Management Program Oncology Department, University Hospital Antwerp, Belgium

Hope Rugo, M.D.Prof5essor of MedicineDirector, Breast Oncology and Clinical Trials EducationUniversity of California San FranciscoHelen Diller Family Comprehensive Cancer CenterSan Francisco, CA

Edgardo S. Santos, M.D., FACPMedical Director of Cancer Research Thoracic and Head and Neck Cancer ProgramsLynn Cancer Institute/Boca Raton Regional HospitalAssociate Professor of Clinical Biomedical ScienceCharles E. Schmidt College of Medicine Florida Atlantic UniversityBoca Raton, FL

Eduardo Sotomayor, M.D.Director, George Washington University Cancer CenterProfessor of Medicine, George Washington University School of Medicine & Health Sciences Washington, DC

Vicente Valero, M.D.Professor, and Deputy Chairman Breast Medical Oncology DepartmentClinical Director, The Morgan Welch Inflammatory Breast Cancer Research Program and Clinic Associate Director, Nellie B. Connally Breast Center The University of Texas M.D. Anderson Cancer CenterHouston, TX

Adrienne M. Vazquez, MSN, ACNP-BC, AOCN Sylvester Comprehensive Cancer CenterUniversity of Miami Miller School of MedicineMiami, FL

Gordana Vlahovic, M.D.Associate Professor of Medicine/Oncology The Preston Robert Tisch Brain Tumor Center at DukeDuke University Medical Center Durham, NC

Nerissa Wood, BSN, RN, OCNClinical Manager, Cancer CenterTulane Medical CenterNew Orleans, LA

Antoinette J. Wozniak, M.D., FACPProfessor of OncologyLeader, Thoracic Multidisciplinary TeamKarmanos Cancer InstituteWayne State UniversityDetroit, MI

12 th AnnuAl new OrleAns summer CAnCer meeting

“Oncogenic Targets and Immune Modulation: Ways to Fight Against Cancer”

DESCRIPTION OF ACTIVITY This is a 3-day national continuing medical education (CME) and nursing education (CE) meeting designed for medical oncologists, hematologists, surgical oncologists, radiation oncologists, oncology nurses, nurse practitioners, pharmacists, physician assistants, residents and fellows in Hematology/Oncology as well as other healthcare professionals involved in the management of cancer patients.

The 12th Annual New Orleans Summer Cancer Meeting (NOSCM) is a major CME/CE event well established in the Southeast region of the United States. In 2017, the meeting has innovations: simultaneous sessions running in parallel, one for physicians and the other one for nurses. Also, a special emphasis has been dedicated to immunotherapy as more clinical indications are coming up as well as different therapeutic compounds with different companion diagnostic tests which require a careful review on the clinical data. Moreover, based on evaluations from the previous 11 consecutive years, this meeting will provide healthcare professionals taken care of cancer patients with the necessary tools to offer the best quality of care to their patients.

The 12th edition of this national CME/CE program will focus on integrating major advances in basic sciences and how to apply them into the routine clinical practice, and hence, deliver customized therapy to each individual patient. In 2017, the Educational Committee decided to continue with topics such as brain tumor, sarcoma, gynecologic malignancies, geriatric oncology and best supportive of care. As we know, all progress in oncology will not be possible if we do not have the support from novel technology in radiation therapy as well as new diagnostic tools such as liquid biopsy. In the 12th NOSCM, discussion on these techniques will take place. The hematology session in 2017 will have the participation of renowned hematologists who will cover the major hematologic malignancies including lymphoma, myeloma and leukemias. The length of the NOSCM allows plenty of time for the audience to discuss in depth different topics in medical oncology and hematology, and share their thoughts with national and international leaders in the field of lung cancer, breast cancer, melanoma, gastrointestinal carcinomas, pancreas, genitourinary malignancies, gynecologic malignancies, head and neck cancer, supportive of care as well as many hematologic malignancies including multiple myeloma, lymphoma, leukemia, and others. The group of guest faculty is represented by expert clinicians and researchers from premier cancer centers in the United States. The most relevant clinical and investigational data presented at major cancer congresses such as the 2016 American Society of Hematology (ASH), the 2017 American Society of Clinical Oncology (ASCO), the 2016 European Society of Medical Oncology, and the 2017 American Association for Cancer Research will be presented and discussed in this forum.

CONFERENCE LEARNING OBJECTIVES Upon completion of “New Orleans Summer Cancer Meeting” attendees will be able to:

• Understand immunomodulation as a therapeutic tool against different tumor types; clinical use of checkpoint inhibitors and others in oncology and hematology.

• Learn how to treat complications from immunotherapy such as pneumonitis, colitis, thyroid disorders, hypophysitis, nephritis, and many others.

• Apply molecular biomarkers results into the treatment algorithm of each individual patient.

• Understand and implement a multidisciplinary approach in the management of brain tumors: radiotherapy, chemotherapy, immu- notherapy and assessing neurological complications.

• Recognize the importance of tumor genetic phenotype in the management of different solid tumor types and malignant hematologic diseases: from prognostic value to predictive impact and potential therapeutic target.

• Learn novel carcinogenic pathways recently discovered as well a new indications from therapies approved by the US FDA for different malignant diseases.

• Learn and apply state-of-the-art management of oncologic patient: Precision Medicine, Alternative Medicine, Supportive of Care, and Survivorship Programs.

• Understand the challenges for oncology practices in 2017: MACRA implementation and other issues.

ACCREDITATION The Medical Educator Consortium is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Medical Educator Consortium designates this live activity for a maximum of 21 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This activity has been submitted to Louisiana State Nurses Associationfor approval to award contact hours. Louisiana State Nurses Association is accredited as an approver of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

DISCLOSURE The Medical Educator Consortium (MEC) adheres to the ACCME Standards for Commercial Support. All persons that will be in a position to control the content of the CME Activity are required to disclose all relevant financial relationships. Faculty disclosure forms outlining this information will be made available to all participants prior to educational activity. MEC has also implemented a mechanism to identify and resolve all conflicts of interest prior to the education activity being delivered to learners. The source of all support from commercial interests will also be disclosed to learners prior to the beginning of the educational activity.

Conference Agenda

7:00 am - 5:45 pm REGISTRATION & VISIT EXHIBITS7:40 am - 8:40 am Breakfast & Learn Symposia (non-CME)8:40 am - 8:50 am Coffee Break and Visit Exhibits 8:50 am - 9:00 am Introduction and Educational Overview of “12th Annual New Orleans Summer Cancer Meeting” – Focus on highlights from the 2016 ASH and 2017 ASCO meetings. Chair: Edgardo S. Santos, M.D. Eugene & Christine E. Lynn Cancer Institute

Neuro-Oncology and RadiotherapyModerator: Ana Botero, M.D.

9:00 am - 9:40 am How to Deal with Metastatic Brain Lesions in the Era of Targeted Therapy and Immunotherapy? Ana Botero, M.D. Memorial Cancer Institute

9:40 am - 10:20 am Brain Tumors: GBM, Oligodendrogliomas, and Others-What is New? Gordana Vlahovic, M.D. Duke University

10:20 am - 11:00 am Management of Neurological Symptoms Secondary to Brain Tumors Therapy as well as Paraneoplastic Syndromes. Sajeel Chowdhary, M.D. Eugene & Christine E. Lynn Cancer Institute

11:00 am - 11:15 am Round Table Discussion and Q & A Session Speakers: Botero, Vhlahovic & Chowdhary

11:15 am - 11:30 am Coffee Break & Visit Exhibits

Gastrointestinal CancersModerator: Eriberto Marques, M.D.

11:30 am - 12:10 pm Colorectal Cancer: Targeted Therapy, Immunotherapy, Novel Pathways? Are We Beyond 5-FU Backbone? John Marshall, M.D. Georgetown University

12:10 pm - 12:50 pm Management of Pancreas and Biliary Tract Carcinomas Mitesh Borad, M.D. Mayo Clinic

12:50 pm - 1:00 pm Round Table Discussion and Q & A Session Speakers: Marshall, Borad & Marques

1:00 pm - 2:00 pm Lunch & Learn Symposia (non-CME)2:00 pm - 2:10 pm Coffee Break & Visit Exhibits

IMMUNOTHERAPY IN ONCOLOGYImmunotherapy Session IModerator: Omid Hamid, M.D.

2:10 pm - 2:40 pm Immunotherapy in Lung Cancer Edgardo S. Santos, M.D. Eugene & Christine E. Lynn Cancer Institute

2:40 pm - 3:10 pm Immunotherapy in Genitourinary Cancers Alan Koletsky, M.D. Eugene & Christine E. Lynn Cancer Institute

3:10 pm - 3:40 pm Immunotherapy in Melanoma Omid Hamid, M.D. The Los Angeles Clinic

3:40 pm - 3:55 pm Round Table Discussion and Q & A session Speakers: Santos, Koletsky, and Hamid

3:55 pm - 4:05 pm Coffee Break & Visit Exhibits

Immunotherapy Session IIModerator: Brian Hunis, M.D.

4:05 pm - 4:35 pm Immunotherapy in Breast and Gynecologic Malignancies: What is on Development? Gerardo Colon-Otero, M.D. Mayo Clinic

4:35 pm - 5:05 pm Immunotherapy in Head and Neck Cancer Brian Hunis, M.D. Memorial Cancer Institute

5:05 pm - 5:35 pm How to Select a Patient for Immunotherapy? Is It For Everyone? Taofeek Owonikoko, M.D. Emory University

5:35 pm - 5:50 pm Round Table Discussion and Q & A Session Speakers: Colon-Otero, Hunis & Owonikoko

FRIDAY, JULY 21

7:00 am - 6:30 pm REGISTRATION & VISIT EXHIBITS

7:40 am - 8:30 am Breakfast & Learn Symposia (non-CME)

8:30 am - 8:40 am Coffee Break & Visit Exhibit

Breast Cancer SessionModerator: Hope Rugo, M.D.

8:40 am - 9:10 am Exploring Novel Pathways in the Bench Lab For Breast Cancer Mark Pegram, M.D. Stanford University

9:10 am - 9:40 am Her-2 Breast Cancer: The Entire Treatment Constellation Hope Rugo, M.D. University of California San Francisco

9:40 am - 10:10 am Hormonal Therapy For All Clinical Settings in Breast Cancer Vicente Valero, M.D. MD Anderson Cancer Center

10:10 am - 10:40 am Triple Negative Breast Cancer: Are We Moving The Outcome Bar Forward? Aurelio Castrellon, M.D. Memorial Cancer Institute

10:40 am - 10:55 am Round Table Discussion and Q & A Session Speakers: Rugo, Pegram, Valero & Castrellon

10:55 am -11:05 am Coffee Break & Visit Exhibits

Gynecologic Maligancy and Geriatric OncologyModerator: Eriberto Marques, M.D.

11:05 am - 11:35 am Novel Advances in the Management of Ovarian, Uterus and Cervical Cancer: PARP Inhibitors and Others (Except Immunotherapy). Thomas Herzog, M.D. University of Cincinnatti Cancer Institute

11:35 am - 12:05 pm Geriatric Oncology Update 2017: What’s new at ASCO and SIOG. Tom Reske, M.D. Louisiana State University

12:05 pm - 12:15 pm Round Table Discussion and Q & A Session Speakers: Herzog & Reske

12:15 pm - 1:15 pm Lunch & Learn Symposia (non-CME)1:15 pm - 1:30 pm Coffee Break & Visit Exhibits

SIMULTANEOUS SESSIONS

ROOM APHYSICIANS’ EDUCATIONAL AFTERNOON SESSSION

Prostate Cancer, Sarcomas, and Supportive of CareModerator: Daniel Petrylak, M.D.

1:30 pm - 2:05 pm Novel Advances In The Management of Castrated Resistant Prostate Cancer Daniel Petrylak, M.D. Yale University

2:05 pm - 2:40 pm Soft Tissue Sarcomas/Liposarcomas/ Leiomyosarcomas: Challenges and Novel Therapies. Pasquale W. Benedetto, M.D. University of Miami Sylvester Cancer Center

2:40 pm - 3:15 pm Use of Bisphosphonates and Anti-RANK Ligand Antibody in Breast Cancer and Other Solid Tumors: Efficacy and Management of Complication such as ONJ. Robert E. Marx, D.D.S. University of Miami Miller School of Medicine

3:15 pm - 3:25 pm Round Table Discussion and Q & A Session Speakers: Petrylak, Benedetto & Marx

3:25 pm - 3:40 pm Coffee Break & Visit Exhibits

ROOM BNURSING EDUCATIONAL AFTERNOON SESSIONModerator: Adrienne Vazquez

Supportive Care Updates After ASCO and ASH Meetings.Survivorship, An Identified Need In Oncology.Coming of Age - Precision Medicine An Individualized Approach. Alternative Medicine, A Nurse’s Response.Top 3 Abstracts of 2017.

1:30 pm - 2:00 pm Supportive Care Updates After ASCO and ASH Meetings. Jessica MacIntyre, ARNP, NP-C University of Miami Sylvester Cancer Center

2:00 pm - 2:30 pm Alternative Medicine, A Nurse’s Response Nerissa Wood, BSN, RN, OCN Tulane University Health Sciences Center

2:30 pm - 3:00 pm Coming of Age - Precision Medicine An Individualized Approach Adrienne Vazquez, MSN, ACNP-BC, AOCNP University of Miami Sylvester Cancer Center

3:00 pm - 3:30 pm Survivorship, an Identified Need in Oncology Jennifer R. Klemp, Ph.D., MPH University of Kansas Medical Center

SATURDAY, JULY 22

Conference Agenda

7:00 am - 12:00 pm REGISTRATION & VISIT EXHIBITS7:40 am - 8:25 am Breakfast & Learn Symposia (non-CME)8:25 am - 8:35 am Coffee Break & Visit Exhibit

Healthcare in The United States of Amercica: Changes In Legislation Co-Sponsor Session by The Louisiana Oncology Society (LOS) and The Florida Society of Clinical Oncology (FLASCO)Moderator: Mrs. Dorothy Green (FLASCO) and Dr. Chancellor Donald (LOS)

8:35 am - 9:05 am National Oncology Issues in 2017: One Topic From Many Mark Diaz, M.D., FLASCO

9:05 am - 9:35 am MACRA: Where Are We Now? Sybil Green, JD, MHA, RPh, ASCO

9:35 am - 9:55 am Round Table Discussion and Q & A Session Speakers: Diaz, S. Green, D. Green, and Donald

Hematology Session IModerator: Eduardo Sotomayor, M.D.

9:55 am - 10:20 am Updates in Chronic Leukemia: CLL and CML Javier Pinilla Ibarz, M.D. H. Lee Moffitt Cancer Center

10:20 am - 10:45 am Non-Hodgkin’s Lymphomas: Top News in B-Cell Malignancies. Eduardo Sotomayor, M.D. George Washington University

10:45 am - 11:10 am Myelodysplasia: What are the Challenges To Treat This Entity and How To Approach Them? Rami Komrokji, M.D. H. Lee Moffitt Cancer Center

11:10 am - 11:20 am Round Table Discussion and Q & A Session Moderator: Pinilla, Sotomayor & Komrokji

11:20 am - 11:35 am Coffee Break & Visit Exhibits

Hematology Session IIModerator: Hugo Fernandez, M.D.

11:35 am - 12:00 pm T-cell NHL: Recent Advances Steven Horwitz, M.D. Memorial Sloan Kettering Cancer Center Center

12:00 pm - 12:25 pm Updates in Acute Leukemia: AML and ALL Hugo Fernandez, M.D. H. Lee Moffitt Cancer Center

12:25 pm - 12:50 pm Multiple Myeloma: Induction, Consolidation and Maintenance Therapy. Sergio Giralt, M.D. Memorial Sloan Kettering Cancer Center

12:50 pm - 1:15 pm Round Table Discussion and Q & A Session Moderator: Horwitz, Fernandez & Giralt

1:15 pm - 1:20 pm Closing Remarks & Conference Outcomes Complete and return conference evaluation forms Chair: Edgardo S. Santos, M.D. Eugene & Christine E. Lynn Cancer Institute

SUNDAY, JULY 23

Conference AgendaSATURDAY, JULY 22 continued

3:30 pm - 4:00 pm Top 3 Abstracts of 2017 (ONS, ASH & ASCO) Lorinda A. Coombs, MSN, FNP-BC, AOCNP University of California San Francisco

4:00 pm - 4:15 pm Round Table Discussion and Q & A Session Speakers: MacIntyre, Wood, Vazquez, Klemp & Coombs

Thoracic Oncology Session Moderator: Luis E. Raez, M.D.

3:40 pm - 4:10 pm Novel Targeted Pathways in Non-Squamous NSCLC: EGFR, ALK, ROS-1, and more Barbara Gitlitz, M.D. University of South California

4:10 pm - 4:40 pm What is the Standard of Care for Squamous Cell NSCLC and Research Efforts For This Histology Luis E. Raez, M.D. Memorial Cancer Institute

4:40 pm - 5:10 pm Novel Carcinogenic Pathways and Novel Therapies for Metastatic NSCLC (except EGFR, ALK, ROS-1) Tarek Mekhail, M.D. Cancer Institute of Florida

5:10 pm - 5:40 pm Small Cell and Neuroendocrine Carcinoma of the Lung Antoinette Wozniak, M.D. Barbara Ann Karmanos Cancer Institute

5:40 pm - 5:50 pm Round Table Discussion and Q & A Session Speakers: Gitlitz, Mekhail, Raez & Wozniak

Special Lecture: Dr. Peter A. Cassileth Memorial Lecture

5:50 pm - 6:20 pm The New Landscape of Lung Cancer Management: Will We Make This a Chronic Disease? Christian Rolfo, M.D. Antwerp University, Belgium

12 th AnnuAl new OrleAns summer CAnCer meeting Register online at www.meccinc.com

Name __________________________________________________________________________ Degree ____________________________

Address ___________________________________________________________________________________________________________

City _________________________________________________ State ______________________ Zip ______________________________

Telephone (_____)______________ _______________________________ Fax (_____) __________________________________________

Email address ______________________________________________________________________________________________________

Specialty __________________________________________________________________________________________________________

Type of Practice: o Private o Academic o Hospital o Resident/Fellow

Registration fee: $ 50 Nurses/Fellows/Residents/ Registration fee: $ 90 Nurses/Fellows/Residents/(Before April 1, 2017) Physician Assistants/Office Staff (After April 1, 2017) Physician Assistants/Office Staff $175 Physicians $225 Physicians $250 Industry Professionals $300 Industry Professionals

I authorize MECC to charge my credit card i/a/o $____________ for registration of this course using the following credit card.

Name on Card ________________________________________________________________ Exp. Date _____________________________

Card number _______________________________________________________________________________________________________

Authorized signer ___________________________________________________________________________________________________

If you require special assistance or have specific dietary requirements, please contact MECC, Inc. no later than June 19, 2017 via email at tvalls@meccinc.com.

Registration Fee(Early Registration Prices, Before April 1, 2017) $50 Nurses/Fellows/Residents/Physician Assistants/Office Staff $175 Physicians $250 Industry Professionals

Registration Fee (After April 1, 2017)$90 Nurses/Fellows/Residents/Physician Assistants/Office Staff$225 Physicians$300 Industry Professionals

Registration fee includes admission to Friday, Saturday & Sunday scientific presentations and handout materials. Re-funds must be provided in writing prior by June 21, 2017. After June 21, 2017, No Refunds will be provided.

Register online at www.meccinc.com

For more information contact:CONFERENCE MANAGEMENTMECC (Meetings Events & Conference Coordinators, Inc)6619 S. Dixie Highway #341 Miami, FL 33143Telephone 305/663-1628 Office Fax 305/675-2718Or visit our website at www.meccinc.com

The Roosevelt Hotel New Orleans123 Baronne Street

New Orleans, LA 70112

Website: www.therooseveltneworleans.com

RESERVATIONS: 1-800-925-3673

ONLINE RESERVATIONS: www.therooseveltneworleans.com and enter the group code “CAN” on the reservations page.

The Roosevelt Hotel provides travelers with a unique haven in the center of the city, blending its rich history and timeless service with the latest amenities. Adjacent to the famed French Quarter, one block from Bourbon St., the Roosevelt is just moments from the Canal Streetcar Line, the Louisiana Super Dome, and Mississippi River attractions.

The Roosevelt is offering special rates during this conference of $175 for King Bed Deluxe accommodation or $185 for a 2 Queen Bed Deluxe Room or $195 for a King Bed Superior Room plus tax. European plan (no meals). The cutoff date to make reservations is June 19, 2017; after this date, reservations are subject to hotel availability. Reservations must be guaranteed by one night’s deposit with a major credit card.

Reservations may be made by calling RESERVATIONS 1-800-925-3673. When making your reservations please identify yourself as attending New Orleans Summer Cancer Meeting, Group Code “CAN” to ensure you receive the group rate.

HOTEL INFORMATION

REGISTRATION FORM

REGISTRATION